Review article · 2026 · Open access

Crosstalk between the cell cycle and ferroptosis in tumor cells

Zongyao Zheng, Xu Lin, Xiang Wang, Jiayan Shen, Nengming Lin

Drug Discovery Today, 31(6), 104848 · Published 30 October 2026 · DOI 10.1016/j.drudis.2026.104848

Open full textCite this paper

In brief

“Crosstalk between the cell cycle and ferroptosis in tumor cells” is a 2026 review article by Zongyao Zheng and 4 co-authors, published in Drug Discovery Today. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Drug Discovery Today.

Citations
0
References
169
Authors
5

Abstract

Cell-cycle regulation shapes ferroptosis through its influences on lipid metabolism, antioxidant defenses, and stress signaling. This review examines how p53, retinoblastoma protein, cyclin-dependent kinases, and DNA damage checkpoints influence ferroptosis in cancer. We reconcile the occurrence of both sensitization and resistance following cell cycle arrest by considering cellular state, arrest duration, lipid storage, redox status, and alternative defense pathways. Drug-tolerant persister cells are distinguished from other slowly proliferating cell populations. Proposed combination treatments remain preclinical, with translation constrained by pharmacokinetics, normal tissue toxicity, tumor heterogeneity, delivery, and unvalidated biomarkers. Functional metabolic assessment is therefore needed alongside cell cycle measurements to guide the future development of therapies that target the cell cycle and ferroptosis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zheng, Z., Lin, X., Wang, X., Shen, J., & Lin, N. (2026). Crosstalk between the cell cycle and ferroptosis in tumor cells. Drug Discovery Today, 31(6), 104848. https://doi.org/10.1016/j.drudis.2026.104848

MLA 9

Zheng, Zongyao, et al. “Crosstalk between the cell cycle and ferroptosis in tumor cells.” Drug Discovery Today, vol. 31, no. 6, 2026, p. 104848. https://doi.org/10.1016/j.drudis.2026.104848.

Chicago

Zheng, Zongyao, Xu Lin, Xiang Wang, Jiayan Shen, and Nengming Lin. 2026. “Crosstalk between the cell cycle and ferroptosis in tumor cells.” Drug Discovery Today 31 (6): 104848. https://doi.org/10.1016/j.drudis.2026.104848.

Harvard

Zheng, Z. et al. (2026) ‘Crosstalk between the cell cycle and ferroptosis in tumor cells’, Drug Discovery Today, 31(6), p. 104848. doi:10.1016/j.drudis.2026.104848.

IEEE

Z. Zheng, X. Lin, X. Wang, J. Shen, and N. Lin, “Crosstalk between the cell cycle and ferroptosis in tumor cells,” Drug Discovery Today, vol. 31, no. 6, p. 104848, 2026, doi: 10.1016/j.drudis.2026.104848.

BibTeX

@article{zheng2026crosstalk,
  title     = {{Crosstalk between the cell cycle and ferroptosis in tumor cells}},
  author    = {Zheng, Zongyao and Lin, Xu and Wang, Xiang and Shen, Jiayan and Lin, Nengming},
  journal   = {Drug Discovery Today},
  year      = {2026},
  volume    = {31},
  number    = {6},
  pages     = {104848},
  doi       = {10.1016/j.drudis.2026.104848},
  url       = {https://doi.org/10.1016/j.drudis.2026.104848}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis

  • ferroptosis
  • cell cycle regulation
  • cancer cells
  • p53
  • retinoblastoma protein
  • cyclin-dependent kinases
  • DNA damage checkpoint
  • cell cycle arrest

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zheng, Z., Lin, X., Wang, X., Shen, J., & Lin, N. (2026). Crosstalk between the cell cycle and ferroptosis in tumor cells. Drug Discovery Today, 31(6), 104848. https://doi.org/10.1016/j.drudis.2026.104848

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Drug Discovery Today: sign in and open the full text from this page.

Who wrote this paper?

Zongyao Zheng, Xu Lin, Xiang Wang, Jiayan Shen, Nengming Lin.

What is the DOI of this paper?

10.1016/j.drudis.2026.104848, permanently at https://doi.org/10.1016/j.drudis.2026.104848. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.